China’s Junlebao Dairy Group has launched a new infant formula, which is said to contain one of the highest lactoferrin content in the market at 468mg/100g of milk powder.
Prior to the launch, the firm has been selling products containing 100mg of lactoferrin in per 100 grams of milk powder, with the goal of increasing lactoferrin content to 2.5g/100g eventually.
This is done to mimic the amount of lactoferrin found in mature breastmilk, according to Celia Ning, who joined the company as the director of Nutrition Research Institute in April.
Singapore firm MD Pharmaceuticals and DSM develop ‘faster-acting’ vitamin D supplement to boost immunity
MD Pharmaceuticals, a Singapore-based healthcare distributor and marketer, has developed a new vitamin D supplement with DSM, which is said to be faster acting for immune health.
Known as Rapid-D, the halal-certified and 100 per cent vegetarian capsule product contains ampli-D – a form of vitamin D3 known as calcifediol and is a trademarked ingredient by DSM.
The product is sold in a box of 30 capsules in selected general practitioner and specialist clinics, as well as the retail pharmacies of Ng Teng Fong General Hospital and Singapore General Hospital.
The cGP Lab Ltd, a New Zealand firm specialising in developing dietary supplements containing cyclic glycine-proline (cGP) – a molecule extracted from New Zealand grown blackcurrants – is eyeing China’s healthy ageing market with its products.
The company currently sells cGPMAX Brain Health capsules – a dietary supplement that claims to support brain function and is also working on new products containing cGP trademarked cGPMAX, but with different functionalities.
As part of its growth plans, the firm would be selling the products into China via cross-border e-commerce (CBEC) in Tmall Global store early next year.
Nestle has launched China’s first carbon-neutral product, a stage three formula for toddlers said to be sourced from Switzerland-based farms that do not use herbicides and growth hormones.
Known as Organic NAN 3, the tin lid and scoop of the product is also said to be made using plant-based materials.
Each tin, which comes in 800g, is said to offset 14.2kg of carbon emission.
Nestle has launched China’s first Foods for Special Medical Purpose (FSMP) for patients suffering from tumour related conditions, after going through a five-year long approval process from the Chinese regulator.
Known as Oral Impact Su Yi Su, the product is also the only FSMP specially approved for nutritional supplementation in this group of patients currently.
Containing arginine and fish oil omega-3 on top of other basic nutritional ingredients, it was formulated to address the problem of inflammation and compromised immunity in patients.